Esta página foi traduzida automaticamente e a precisão da tradução não é garantida. Por favor, consulte o versão em inglês para um texto fonte.

Pregnancy With Insomnia: a Trial of Acupuncture (GAS)

27 de junho de 2017 atualizado por: Assistance Publique - Hôpitaux de Paris

Acupuncture is widely used for treatment of insomnia. The research hypothesis is that acupuncture may be more effective than sham acupuncture to treat insomnia during pregnancy.

GAS is a randomized controlled trial with placebo acupuncture using the insomnia severity index (ISI) as the main outcome criterion.

Visão geral do estudo

Status

Desconhecido

Condições

Intervenção / Tratamento

Descrição detalhada

Scientific justification:

- During pregnancy, insomnia occurs mainly in women without a previous history of sleep disorder, and may remain after delivery. Insomnia affects the quality of life. It might be associated with an increase in labor duration and cesarean section rate.

Insomnia tends to worsen during gestation, owing to back pain, an increased need to micturate, and the movement of the fetus. Sleep disorders are often associated with restless legs syndrome.

  • To treat insomnia during pregnancy, the Haute Autorité de Santé (HAS) recommends avoiding using psychotropic medications. It also recommends screening for depression or anxiety traits often associated with insomnia. However, in most cases, psychological means alone fail to treat insomnia effectively.
  • Based on 11 randomized controlled trials, the odds of improving sleep disorders are 3 times greater with than without acupuncture, but the methodological quality of these trials is considered insufficient to conclude.

Population:

The study focused on pregnant women suffering from insomnia, excluding women with pregnancies complicated by pre-eclampsia, fetal growth anomalies, or threatened premature labor for fear those complications might interact with sleep disorders, as well as women with known psychiatric disorders. We also excluded women with a history of insomnia before pregnancy to focus on insomnia triggered by pregnancy only.

Objectives:

  • Primary objective: To assess the effect of a standardized acupuncture protocol vs. placebo on insomnia during pregnancy.
  • Secondary objectives: To assess the effect of a standardized acupuncture protocol vs. placebo on (i) the Pittsburgh Sleep Quality Index (PSQI), (ii) anxiety and depression traits, (iii) use of psychotropic medicines and (iv) recreational substances, (v) the incidence of restless legs syndrome, (vi) perinatal outcome .

Study design:

  • Study Type: Multicentre, Interventional, randomized, 2 parallel groups
  • Endpoint Classification: Efficacy Study
  • Intervention Model: Parallel Assignment
  • Masking: Single blind (patient blinded to intervention)
  • Primary Purpose: Treatment
  • One acupuncture session weekly for 4 consecutive weeks

Visits:

  • Selection: When a pregnant woman complains from insomnia, the health professional in charge will fill a checklist of inclusion and exclusion criteria, provide the patient with a pre inclusion ISI questionnaire and give the patient an information sheet and a copy of the consent. When a pregnant woman is sent to the acupuncturist for sleep disorders, he or she may proceed to the selection visit.
  • Inclusion: The acupuncturist checks for inclusion and exclusion criteria, collects the patient written consent, performs the clinical examination, gives the corresponding self-assessment questionnaires and proceeds to computerized randomization.
  • Follow-up: At visits 1 to 4, the acupuncturist performs the treatment, and records side effects if any. Visits are scheduled on a weekly basis.
  • End of research: At visit 5 (one week after last acupuncture session), the acupuncturist gives the corresponding self-assessment questionnaires.

Tipo de estudo

Intervencional

Inscrição (Antecipado)

60

Estágio

  • Não aplicável

Contactos e Locais

Esta seção fornece os detalhes de contato para aqueles que conduzem o estudo e informações sobre onde este estudo está sendo realizado.

Critérios de participação

Os pesquisadores procuram pessoas que se encaixem em uma determinada descrição, chamada de critérios de elegibilidade. Alguns exemplos desses critérios são a condição geral de saúde de uma pessoa ou tratamentos anteriores.

Critérios de elegibilidade

Idades elegíveis para estudo

18 anos e mais velhos (Adulto, Adulto mais velho)

Aceita Voluntários Saudáveis

Não

Gêneros Elegíveis para o Estudo

Fêmea

Descrição

Inclusion Criteria:

  • Age > 18 years
  • Singleton pregnancy
  • Gestational age ≥ 16 weeks + 0 day and ≤ 32 weeks + 6 days
  • Insomnia Severity Index ≥ 10
  • Insomnia reported to have started during pregnancy and at least 2 weeks before inclusion
  • Patient understanding the study
  • Informed consent signed
  • Social insurance available at inclusion and until the end of pregnancy

Exclusion Criteria:

  • Threatened premature labor
  • Small fetus for gestational age
  • Pre-eclampsia
  • Insomnia starting before pregnancy
  • Use of psychotropic drugs before pregnancy
  • Use of recreational drugs during pregnancy
  • Known psychiatric disorder
  • Anticoagulant therapy
  • Patient reporting insomnia results from chronic or acute pain
  • Obstructive sleep apnea (OSA) requiring treatment
  • Patient under antidepressant therapy
  • Patient under legal guardianship or deprived of freedom

Plano de estudo

Esta seção fornece detalhes do plano de estudo, incluindo como o estudo é projetado e o que o estudo está medindo.

Como o estudo é projetado?

Detalhes do projeto

  • Finalidade Principal: Tratamento
  • Alocação: Randomizado
  • Modelo Intervencional: Atribuição Paralela
  • Mascaramento: Solteiro

Armas e Intervenções

Grupo de Participantes / Braço
Intervenção / Tratamento
Experimental: Regular acupuncture needles
Real acupuncture procedure The real acupuncture will be performed by means of standard stainless-steel needles (0.30-mm diameter, 30-mm length/Gauge 8 x 1.2"), located bilaterally in 5 real acupoints.
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes
Comparador Falso: Sham acupuncture needles
Sham acupuncture with a no penetrating sham needle (blunt and telescopic), giving the impression of insertion but without penetrating the skin will be placed bilaterally in 5 false acupoints
The patient will be in a semi recumbent position during needle penetration. Duration of needle insertion: 30 minutes

O que o estudo está medindo?

Medidas de resultados primários

Medida de resultado
Descrição da medida
Prazo
Insomnia severity index (ISI)
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of ISI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session

Medidas de resultados secundários

Medida de resultado
Descrição da medida
Prazo
Pittsburgh Sleep Quality Index (PSQI)
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of PSQI self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Hospital Anxiety and Depression Scale (HADS)
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
Difference of HADS self-report questionnaire administrated at inclusion visit and 5 weeks after the first acupuncture session
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of each psychotropic medicine
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of any drug.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of alcohol
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of alcohol.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of tobacco
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of tobacco.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of cannabis
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of cannabis.
Inclusion visit and 5 weeks after the first acupuncture session
Cumulated dose of other recreational substances or medicine
Prazo: Inclusion visit and 5 weeks after the first acupuncture session
During the study period, the patients will note on a logbook the daily use of other recreational substances and medicine.
Inclusion visit and 5 weeks after the first acupuncture session
Difference in the frequency of restless leg syndrome
Prazo: Inclusion visit and 5 weeks after the first acupuncture session

According to the guidelines of the International Restless Legs Syndrome Study Group.

The diagnosis of restless leg will rely on the presence of all of the following criteria:

  1. Desire to move the extremities usually associated with discomfort or disagreeable sensations in the extremities.
  2. Motor Restlessness-patients move to relieve the discomfort, for example walking, or to provide a counter-stimulus to relieve the discomfort, for example, rubbing the legs.
  3. Symptoms are worse at rest with at least temporary relief by activity.
  4. Symptoms are worse later in the day or at night.
Inclusion visit and 5 weeks after the first acupuncture session
Perinatal outcome - Gestational age at birth
Prazo: At birth
The gestational age at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth weight
Prazo: At birth
The weight (in gr) at birth of the newborn will be recorded.
At birth
Perinatal outcome - birth height
Prazo: At birth
The height (in cm) at birth of the newborn will be recorded.
At birth
Perinatal outcome - sex
Prazo: At birth
The sex of the newborn will be recorded.
At birth
Perinatal outcome - perinatal mortality
Prazo: At birth
The perinatal mortality will be recorded.
At birth
Perinatal outcome - five minutes Apgar score
Prazo: At birth
The five minutes Apgar score will be recorded.
At birth
Perinatal outcome - cesarean section rate
Prazo: At birth.
Cesarean section rate will be recorded.
At birth.

Colaboradores e Investigadores

É aqui que você encontrará pessoas e organizações envolvidas com este estudo.

Investigadores

  • Investigador principal: Stéphanie Nicolian, Midewife, Assistance Publique - Hôpitaux de Paris

Datas de registro do estudo

Essas datas acompanham o progresso do registro do estudo e os envios de resumo dos resultados para ClinicalTrials.gov. Os registros do estudo e os resultados relatados são revisados ​​pela National Library of Medicine (NLM) para garantir que atendam aos padrões específicos de controle de qualidade antes de serem publicados no site público.

Datas Principais do Estudo

Início do estudo (Antecipado)

1 de setembro de 2017

Conclusão Primária (Antecipado)

1 de janeiro de 2019

Conclusão do estudo (Antecipado)

1 de maio de 2019

Datas de inscrição no estudo

Enviado pela primeira vez

23 de maio de 2017

Enviado pela primeira vez que atendeu aos critérios de CQ

19 de junho de 2017

Primeira postagem (Real)

21 de junho de 2017

Atualizações de registro de estudo

Última Atualização Postada (Real)

28 de junho de 2017

Última atualização enviada que atendeu aos critérios de controle de qualidade

27 de junho de 2017

Última verificação

1 de abril de 2017

Mais Informações

Termos relacionados a este estudo

Plano para dados de participantes individuais (IPD)

Planeja compartilhar dados de participantes individuais (IPD)?

Não

Informações sobre medicamentos e dispositivos, documentos de estudo

Estuda um medicamento regulamentado pela FDA dos EUA

Não

Estuda um produto de dispositivo regulamentado pela FDA dos EUA

Não

produto fabricado e exportado dos EUA

Não

Essas informações foram obtidas diretamente do site clinicaltrials.gov sem nenhuma alteração. Se você tiver alguma solicitação para alterar, remover ou atualizar os detalhes do seu estudo, entre em contato com register@clinicaltrials.gov. Assim que uma alteração for implementada em clinicaltrials.gov, ela também será atualizada automaticamente em nosso site .

Se inscrever